News | June 2, 2021

FindMeCure Ltd Releases An Overview Of The 2021 Clinical Research Market

FindMeCure Ltd, a technology company based in the UK, announced the release of their 2021 clinical research market overview. The company was created with the goal of bringing clinical research closer to patients. Their cloud-based tool, TrialHub, supports professionals at the planning stages of clinical trials by providing them with real-time data and real-life insights of local experts.

FindMeCure’s commitment to support the industry during the pandemic led to the team collecting and analysing data about started clinical trials in all therapeutic areas and 70 countries. Their efforts were motivated by questions around Covid-19’s impact on therapeutic areas and geographical regions that were growing research-wise in 2019.

The 2021 Market Overview (https://bit.ly/3p3CnYC) highlights trends in the industry spanning 2018, 2019, 2020 and Q1 of 2021. Updates are made regularly as new data about started clinical trials becomes available.

In the Overview, therapeutic areas are ranked in terms of the amount of research done in them in a given year compared to the previous one. The team asks questions about therapeutic areas most and least negatively affected by Covid-19 and TAs recovering in Q1 of this year.

Similarly, geographical regions are discussed in terms of the amounts of research done compared to the previous year. Q1 of 2021 marks some interesting developments as trials put on pause in 2020 are slow to resume while Covid-19 research is going down where cases are too few for successful recruitment.

The data in this Overview comes from FindMeCure’s clinical trial planning platform - TrialHub. TrialHub aggregates thousands of data sources in real-time and combines them with the experience of local country advisors to support winning clinical trial strategies.

Source: FindMeCure Ltd.